1. Home
  2. Labeler Index
  3. Indoco Remedies Limited
  4. 14445-414
  5. NDC Package Code: 14445-414-01 Neostigmine Methylsulfate

NDC Package 14445-414-01 Neostigmine Methylsulfate

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
14445-414-01
Package Description:
10 CARTON in 1 PACKAGE / 1 VIAL, MULTI-DOSE in 1 CARTON (14445-414-10) / 10 mL in 1 VIAL, MULTI-DOSE
Product Code:
14445-414
Proprietary Name:
Neostigmine Methylsulfate
Non-Proprietary Name:
Neostigmine Methylsulfate
Substance Name:
Neostigmine Methylsulfate
Usage Information:
Neostigmine methylsulfate injection is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.
11-Digit NDC Billing Format:
14445041401
NDC to RxNorm Crosswalk:
  • RxCUI: 311935 - neostigmine methylsulfate 0.5 MG/ML Injectable Solution
  • RxCUI: 311936 - neostigmine methylsulfate 1 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Indoco Remedies Limited
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • NEOSTIGMINE METHYLSULFATE 1 mg/mL
    • Pharmacologic Class(es):
  • Cholinesterase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Cholinesterase Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA210652
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-26-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 14445-414-01?

    The NDC Packaged Code 14445-414-01 is assigned to a package of 10 carton in 1 package / 1 vial, multi-dose in 1 carton (14445-414-10) / 10 ml in 1 vial, multi-dose of Neostigmine Methylsulfate, a human prescription drug labeled by Indoco Remedies Limited. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 14445-414 included in the NDC Directory?

    Yes, Neostigmine Methylsulfate with product code 14445-414 is active and included in the NDC Directory. The product was first marketed by Indoco Remedies Limited on October 26, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 14445-414-01?

    The 11-digit format is 14445041401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-214445-414-015-4-214445-0414-01